Dermata Therapeutics, Inc.

Nasdaq:DRMANasdaq:DRMAW

Pharmaceutical Preparations·SAN DIEGO, CA

CEO

Proehl Gerald T

CFO

Van Hoose Kyri K.

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/17/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/7/24	→
↓

Earnings Releases (8-K)

18 shown

Filed	Period
11/14/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/17/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/7/24	Q3 FY2024	→
↓

News (8-K)

53 shown

Filed	Type	Description
2/25/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/3/26	Other	Changes in Registrant's Certifying Accountant	→
1/27/26	Other	Other Events	→
12/29/25	Agreement	Entry into a Material Definitive Agreement	→
11/18/25	Other	Termination of a Material Definitive Agreement	→
11/7/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/29/26	424B3	424B3	→
1/27/26	424B5	424B5	→
1/22/26	S-3	S-3	→
11/24/25	S-3	S-3	→
11/7/25	424B5	424B5	→
6/2/25	ARS	ARS	→
↓

Filing History(338 filings)

TypeDateAccessionPeriodSize

8-K

Feb 25, 2026

0001493152-26-0080378-K

Feb 23, 2026

244.6 KB

SCHEDULE 13D/A

Feb 23, 2026

0001493152-26-007792

—

8.5 KB

SCHEDULE 13G/A

Feb 18, 2026

0001172661-26-001308

—

10.3 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001248

—

10.2 KB

SCHEDULE 13G/A

Feb 9, 2026

0000921895-26-000261

—

21.2 KB

8-K

Feb 3, 2026

0001493152-26-0049058-K

Jan 30, 2026

256.8 KB

SCHEDULE 13D/A

Feb 2, 2026

0001493152-26-004801

—

8.6 KB

EFFECT

Jan 29, 2026

9999999995-26-000354

—

1.7 KB

424B3

Jan 29, 2026

0001493152-26-004247424B3

—

251.7 KB

8-K

Jan 27, 2026

0001493152-26-0037158-K

Jan 27, 2026

291.5 KB

424B5

Jan 27, 2026

0001493152-26-003706424B5

—

16.2 KB

S-3

Jan 22, 2026

0001493152-26-003259S-3

—

520.5 KB

SCHEDULE 13D/A

Jan 8, 2026

0001493152-26-000967

—

14.1 KB

Jan 7, 2026

0001493152-26-000797

—

14.6 KB

Jan 6, 2026

0001493152-26-000698

Jan 2, 2026

5.6 KB

Jan 6, 2026

0001493152-26-000703

Jan 2, 2026

5.5 KB

Jan 6, 2026

0001493152-26-0006994

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-000704

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-0006974

Jan 2, 2026

5.5 KB

Jan 6, 2026

0001493152-26-000702

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-0006964

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-0007014

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-000695

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-0007004

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001493152-26-0006944

Jan 2, 2026

5.5 KB

25 filings shown

Filed	Form	Description
6/2/25	DEFA14A	DEFA14A	→
6/2/25	DEF 14A	DEF 14A	→
5/23/25	PRE 14A	PRE 14A	→
3/26/24	DEFA14A	DEFA 14A	→
3/26/24	DEF 14A	DEF 14A	→
3/4/24	PRE 14A	PRE 14A	→
↓

Dermata Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(338 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
↓

Filed	Form	Description
2/23/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/18/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/2/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
1/29/26	EFFECT	EFFECT	→
↓